Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

Imricor Medical Systems Inc

Healthcare AU IMR

1.26AUD
-0.03(2.33%)

Last update at 2025-07-25T05:59:00Z

Day Range

1.251.34
LowHigh

52 Week Range

0.461.85
LowHigh

Fundamentals

  • Previous Close 1.29
  • Market Cap406.97M
  • Volume206029
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-15.54865M
  • Revenue TTM0.96M
  • Revenue Per Share TTM0.004
  • Gross Profit TTM -0.92412M
  • Diluted EPS TTM-0.2

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -17.35627M -19.73254M -12.44647M -13.29398M -5.44848M
Minority interest - - - - -
Net income -17.53418M -20.55611M -13.07680M -14.79815M -5.44848M
Selling general administrative 4.98M 5.82M 4.33M 2.64M 2.29M
Selling and marketing expenses 2.80M 2.87M 1.68M 0.57M -
Gross profit -1.52678M -1.89592M -0.39767M 0.26M 1.00M
Reconciled depreciation 0.71M 0.69M 0.53M 0.26M -
Ebit -17.17835M -19.62369M -12.14584M -12.26324M -4.81724M
Ebitda -16.46586M -18.93458M -11.61775M -12.00594M -
Depreciation and amortization 0.71M 0.69M 0.53M 0.26M -
Non operating income net other - - - - -
Operating income -17.17835M -19.62369M -11.61775M -12.00594M -4.81724M
Other operating expenses 18.81M 21.74M 13.21M 13.39M -
Interest expense 0.18M 0.11M 0.30M 1.03M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.11M 0.02M 0.04M 0.80M 0.63M
Net interest income -0.06992M -0.09212M -0.35238M -1.45144M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.18M 0.82M 0.63M 1.50M -
Total revenue 0.82M 0.70M 0.70M 0.64M 1.00M
Total operating expenses 16.47M 19.15M 12.11M 13.01M 5.82M
Cost of revenue 2.34M 2.59M 1.10M 0.38M -
Total other income expense net -0.17792M -0.10885M -0.82873M -1.28803M -0.63124M
Discontinued operations - - - - -
Net income from continuing ops -17.35627M -19.73254M -16.16005M -18.97513M -5.44848M
Net income applicable to common shares -17.35627M -19.73254M -12.44647M -13.29398M -5.44848M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 21.62M 12.18M 13.70M 26.86M 33.57M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.79M 1.52M 1.59M 1.51M 0.49M
Total liab 29.00M 25.00M 6.19M 4.46M 4.75M
Total stockholder equity -7.37703M -12.82827M 7.51M 22.40M 28.82M
Deferred long term liab - - - - -
Other current liab 1.55M 1.16M 0.02M 0.18M 0.50M
Common stock 0.03M 0.02M 97.47M 95.01M 81.69M
Capital stock - - 97.47M 95.01M 81.69M
Retained earnings -142.27972M -164.99880M -89.96098M -72.60472M -52.87218M
Other liab - - 0.54M 0.51M 0.62M
Good will - - - - -
Other assets - - 0.23M 0.57M 0.75M
Cash 15.71M 1.22M 5.69M 18.52M 25.14M
Cash and equivalents - - - - -
Total current liabilities 2.36M 6.70M 2.07M 2.74M 2.30M
Current deferred revenue - 0.85M 0.92M 1.35M 1.07M
Net debt 5.51M 14.48M -1.19781M -16.77856M -23.75387M
Short term debt 0.47M 1.60M 0.87M 0.52M 0.20M
Short long term debt - - - - -
Short long term debt total 21.21M 15.70M 4.49M 1.74M 1.39M
Other stockholder equity 134.88M 152.15M - - 2.14M
Property plant equipment - - 3.56M 3.60M 3.89M
Total current assets 18.35M 5.77M 9.68M 22.70M 28.92M
Long term investments - - - - -
Net tangible assets - - 7.51M 22.40M 28.82M
Short term investments - - - - -
Net receivables 0.35M 0.58M 0.13M 0.09M 0.22M
Long term debt - - 2.18M - -
Inventory 1.50M 2.46M 2.28M 2.58M 3.07M
Accounts payable 0.33M 3.08M 0.26M 0.69M 0.53M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -2.13881M
Additional paid in capital - - - - -
Common stock total equity - - - - 106.06M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.68M 1.49M 0.46M 0.57M 0.75M
Deferred long term asset charges - - - - -
Non current assets total 3.27M 6.40M 4.02M 4.17M 4.64M
Capital lease obligations - - 2.31M 1.74M 1.80M
Long term debt total - - 2.25M 0.23M 0.67M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.23886M -0.06956M -1.00498M -0.75555M -0.06956M
Change to liabilities -0.57287M 0.24M -0.29858M 0.26M -0.25280M
Total cashflows from investing activities -0.23886M -0.69530M -0.77403M -0.52934M -0.15059M
Net borrowings 1.97M -0.58130M -0.38244M 3.23M 4.74M
Total cash from financing activities 3.94M 11.59M 33.02M 10.45M 4.70M
Change to operating activities 0.11M -0.60549M 0.74M 0.18M 0.01M
Net income -17.53418M -19.73254M -12.97456M -13.55128M -5.44848M
Change in cash -12.82839M -6.62360M 20.09M 3.46M -0.18073M
Begin period cash flow 18.52M 25.14M 5.05M 1.59M -
End period cash flow 5.69M 18.52M 25.14M 5.05M 2.27M
Total cash from operating activities -16.82169M -17.48855M -12.23069M -6.62799M -4.73385M
Issuance of capital stock 4.37M 12.17M 33.41M 7.22M -
Depreciation 0.71M 0.69M 0.53M 0.26M 0.08M
Other cashflows from investing activities 0.00000M -0.06956M -0.03215M -0.16458M -0.00386M
Dividends paid - - - - -
Change to inventory -0.44497M -0.18136M -1.84930M -0.84630M -0.22640M
Change to account receivables -0.06822M 0.15M 0.07M -0.16097M 0.03M
Sale purchase of stock -0.07067M 12.17M 33.41M 7.22M 0.01M
Other cashflows from financing activities 0.51M -0.58130M -0.38244M 3.23M -0.04935M
Change to netincome 1.01M 1.94M 1.02M 2.67M 0.82M
Capital expenditures 0.24M 0.63M 0.74M 0.36M 0.15M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.97767M -0.38914M -1.33266M -0.56636M -0.44087M
Stock based compensation - - - - -
Other non cash items 16.82M 19.04M 11.92M 13.29M -
Free cash flow -17.06055M -18.11429M -12.97258M -6.99275M -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IMR
Imricor Medical Systems Inc		 -0.03 2.33% 1.26 - - 424.18 3.97 288.25 -2.6027
COH
Cochlear Ltd		 -1.18 0.38% 312.83 55.54 46.30 8.90 10.89 8.75 33.84
PNV
Polynovo Ltd		 -0.035 2.64% 1.29 134.50 63.29 8.04 12.12 7.81 98.10
EBR
Ebr Systems Inc CDR		 -0.025 1.84% 1.33 - - - 22.76 -3.6785
AVH
Avita Therapeutics Inc		 -0.14 7.25% 1.79 - 5.95 3.48 7.17 2.56 -10.0538

Reports Covered

Stock Research & News

View All

Profile

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Imricor Medical Systems Inc

400 Gateway Boulevard, Burnsville, MN, United States, 55337

Key Executives

Name Title Year Born
Mr. Steve Wedan Pres, CEO & Exec. Chairman 1969
Mr. Gregg Stenzel Chief Operating Officer NA
Mr. Jonathon Gut CFO, Controller, Director & VP of Fin. NA
Mr. Greg Englehardt Exec. Director of Sales NA
Mr. Nick Twohy VP of Marketing & Bus. Devel. NA
Mr. Kobe Lizheng Company Sec. & Local Agent NA
Mr. Steve Wedan President, CEO & Executive Chairman 1969
Mr. Jonathon Gut CFO, Controller, Director & VP of Finance NA
Mr. Greg Englehardt Senior Director of Sales NA
Mr. Steve Wedan President, CEO & Executive Chairman 1969

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.